ONLINE DATABASE SEARCH -
HIV-LS-381-MEMO
1.
61485 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
HIV fusion inhibitor peptides derived from HIV gp41 with improved
pharmacological properties, solubility and stability, and anti-AIDS
uses
Dwyer, John J, Bray, Brian L, Schneider, Stephen E, Zhang, Huyi,
Tvermoes, Nicolai A, Johnston, Barbara E, and Friedrich, Paul
E
PATENT: US
2007179278 ISSUE DATE: 20070802
APPLICATION: 2007-46550 PP:
38pp.
ASSIGNEE: (Trimeris, Inc.
USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
2.
61486 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
Pyrimidine mononucleotide and mononucleoside compounds for use in
therapy, particularly as antitumor and antiviral agents
Aradi, Janos, Fesues, Laszlo, and Beck, Zoltan
PATENT: WO
2007083173 ISSUE DATE: 20070726
APPLICATION: 2007 PP:
37pp.
ASSIGNEE: (University of
Debrecen, Hung.
View Data on the NIAID Therapeutics Website
HYPERLINK:
3.
61487 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
Preparation of oxazole derivatives as antiviral agents
Bajji, Ashok C, Kim, Se-Ho, Trovato, Richard, Mchugh, Robert J,
Markovitz, Benjamin, and Anderson, Mark B
PATENT: WO
2007076161 ISSUE DATE: 20070705
APPLICATION: 2006 PP:
116pp.
ASSIGNEE: (Myriad Genetics,
Inc USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
4.
61488 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
Bis(trihydroxystyrenesulfonyl)methanes as viral entry inhibitors and
preparation of related compounds as HIV integrase inhibitors
Gervay-Hague, Jacquelyn, Meadows, Christopher D, North, Thomas W, and
Duong, Yen T
PATENT: WO
2007065032 ISSUE DATE: 20070607
APPLICATION: 2006 PP:
61pp.
ASSIGNEE: (The Regents of
the University of California, USA
View Data on the NIAID Therapeutics Website
HYPERLINK:
5.
61489 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
Discovery and optimization of a natural HIV-1 entry inhibitor targeting
the gp41 fusion peptide
Muench, Jan, Staendker, Ludger, Adermann, Knut, Schulz, Axel, Schindler,
Michael, Chinnadurai, Raghavan, Poehlmann, Stefan, Chaipan, Chawaree, Biet,
Thorsten, Peters, Thomas, Meyer, Bernd, Wilhelm, Dennis, Lu, Hong, Jing, Weiguo,
Jiang, Shibo, Forssmann, Wolf-Georg, and Kirchhoff, Frank
Cell (Cambridge, MA, U. S.) 2007. 129(2): 263-275
View Data on the NIAID Therapeutics Website
HYPERLINK:
6.
61490 HIV-LS-381;
WOS-HIV-8/10/2007
Anti-Stress, Anti-Hiv and Vitamin C-Synergized Radical Scavenging
Activity of Mulberry Juice Fractions
Sakagami, H. et al.
In Vivo 2007. 21(3):
499-505
View Data on the NIAID Therapeutics Website
HYPERLINK:
http://publishorperish.nih.gov/Gateway.cgi?KeyUT=000247165300009
7.
61491 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
The a(1,2)-mannosidase I inhibitor 1-deoxymannojirimycin potentiates the
antiviral activity of carbohydrate-binding agents against wild-type and mutant
HIV-1 strains containing glycan deletions in gp120
Balzarini, Jan
FEBS Lett. 2007.
581(10): 2060-2064
View Data on the NIAID Therapeutics Website
HYPERLINK:
8.
61492 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
Molecular umbrellas: a novel class of candidate topical microbicides to
prevent human immunodeficiency virus and herpes simplex virus
infections
Madan, Rebecca Pellett, Mesquita, Pedro MM, Cheshenko, Natalia, Jing,
Bingwen, Shende, Vikas, Guzman, Esmeralda, Heald, Taylor, Keller, Marla J,
Regen, Steven L, Shattock, Robin J, and Herold, Betsy C
J. Virol. 2007.
81(14): 7636-7646
View Data on the NIAID Therapeutics Website
HYPERLINK:
9.
61493 HIV-LS-381;
SCIFINDER-HIV-8/13/2007
Preparation of amino acid hydrazide derivatives as HIV protease
inhibitors
Sund, Christian, Lindborg, Bjoern, Kalayanov, Genadiy, Samuelsson,
Bertil, Wallberg, Hans, and Hallberg, Anders
PATENT: WO
2007048557 ISSUE DATE: 20070503
APPLICATION: 2006 PP:
85pp.
ASSIGNEE: (Medivir AB,
Swed.
View Data on the NIAID Therapeutics Website
HYPERLINK:
10.
61494 HIV-LS-381;
PUBMED-HIV-8/20/2007
Darunavir (TMC114): a new HIV-1 protease inhibitor
Molina, JM and Hill, A
Expert Opin Pharmacother 2007. 8(12): 1951-1964
View Data on the NIAID Therapeutics Website
HYPERLINK:
11.
61495 HIV-LS-381;
PUBMED-HIV-8/20/2007
Potent New Antiviral Compound Shows Similar Inhibition and Structural
Interactions with Drug Resistant Mutants and Wild Type HIV-1
Protease
Wang,
YF, Tie, Y, Boross, PI, Tozser, J, Ghosh, AK, Harrison, RW, and Weber,
IT
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
12.
61496 HIV-LS-381;
PUBMED-HIV-8/20/2007
Design and Synthesis of HIV-1 Protease Inhibitors Incorporating
Oxazolidinones as P2/P2' Ligands in Pseudosymmetric Dipeptide
Isosteres
Reddy, GS, Ali, A, Nalam, MN, Anjum, SG, Cao, H, Nathans, RS, Schiffer,
CA, and Rana, TM
J Med Chem 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
13.
61497 HIV-LS-381;
PUBMED-HIV-8/20/2007
HIV-1 protease and HIV-1 integrase inhibitory substances from Eclipta
prostrata
Tewtrakul, S, Subhadhirasakul, S, Cheenpracha, S, and Karalai,
C
Phytother Res 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
14.
61498 HIV-LS-381;
PUBMED-HIV-8/20/2007
Characterization and Structural Analysis of Novel Mutations in HIV-1
Reverse Transcriptase Involved in the Regulation of Resistance to Non-Nucleoside
Inhibitors
Ceccherini-Silberstein, F, Svicher, V, Sing, T, Artese, A, Santoro, MM,
Forbici, F, Bertoli, A, Alcaro, S, Palamara, G, d'Arminio, Monforte A,
Balzarini, J, Antinori, A, Lengauer, T, and Perno, CF
J
Virol 2007.
View Data on the NIAID Therapeutics Website
HYPERLINK:
15.
61499 HIV-LS-381;
PUBMED-HIV-8/20/2007
Inhibition of HIV replication: A powerful antiviral strategy by IFN-beta
gene delivery in CD4(+) cells
Brule, F, Khatissian, E, Benani, A, Bodeux, A, Montagnier, L, Piette, J,
Lauret, E, and Ravet, E
Biochem Pharmacol 2007.
74(6): 898-910